Symphony Financial Services Inc. Sells 261 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Symphony Financial Services Inc. lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 25.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 771 shares of the healthcare conglomerate’s stock after selling 261 shares during the period. Symphony Financial Services Inc.’s holdings in UnitedHealth Group were worth $390,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter worth $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Legacy Investment Solutions LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $57,000. Finally, DecisionPoint Financial LLC lifted its position in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $474.58 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market capitalization of $436.74 billion, a P/E ratio of 30.62, a P/E/G ratio of 1.37 and a beta of 0.61. The firm’s 50 day simple moving average is $515.18 and its two-hundred day simple moving average is $555.37.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analyst Ratings Changes

Several equities research analysts have recently commented on UNH shares. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.